Rua Bioscience Limited (RUA.NZ)
NZD 0.03
(0.0%)
NZD 0.03
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -747.35 Thousand NZD | 69.05% |
| 2023 | -2.41 Million NZD | -124.99% |
| 2022 | -1.07 Million NZD | 52.12% |
| 2021 | -2.24 Million NZD | 37.54% |
| 2020 | -3.58 Million NZD | 9.29% |
| 2019 | -3.95 Million NZD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -747.35 Thousand NZD | 69.05% |
| 2024 Q1 | -848.24 Thousand NZD | 64.87% |
| 2024 Q4 | -747.35 Thousand NZD | 0.0% |
| 2024 Q2 | -804.58 Thousand NZD | 5.15% |
| 2023 Q3 | -2.46 Million NZD | -64.16% |
| 2023 Q1 | -1.58 Million NZD | -47.69% |
| 2023 Q4 | -2.41 Million NZD | 1.9% |
| 2023 FY | -2.41 Million NZD | -124.99% |
| 2023 Q2 | -1.49 Million NZD | 5.41% |
| 2022 Q1 | -1.51 Million NZD | 32.53% |
| 2022 FY | -1.07 Million NZD | 52.12% |
| 2022 Q4 | -1.07 Million NZD | 10.7% |
| 2022 Q3 | -1.2 Million NZD | 11.52% |
| 2022 Q2 | -1.35 Million NZD | 10.19% |
| 2021 Q1 | -18.98 Million NZD | -429.09% |
| 2021 Q3 | -2.53 Million NZD | 86.57% |
| 2021 Q4 | -2.24 Million NZD | 11.71% |
| 2021 Q2 | -18.89 Million NZD | 0.47% |
| 2021 FY | -2.24 Million NZD | 37.54% |
| 2020 FY | -3.58 Million NZD | 9.29% |
| 2020 Q4 | -3.58 Million NZD | 8.61% |
| 2020 Q3 | -3.92 Million NZD | 0.0% |
| 2020 Q1 | 6.17 Million NZD | 0.0% |
| 2019 FY | -3.95 Million NZD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AFT Pharmaceuticals Limited | 20.14 Million NZD | 103.709% |
| Greenfern Industries Limited | 668.43 Thousand NZD | 211.806% |